Pulmonary delivery of nano‐particles for lung cancer diagnosis and therapy: Recent advances and future prospects
WIREs Nanomedicine and Nanobiotechnology · 2024
DOI: 10.1002/wnan.1933 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, 2024. Verfasst von Rong A und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Nanoparticles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 150 Literaturangaben. Gefördert von: Heilongjiang Provincial Key Laboratory of Molecular Imaging foundation, HMU Marshal Initiative Funding, National Natural Science Foundation of China.
Abstract (Originalsprache)
Although our understanding of lung cancer has significantly improved in the past decade, it is still a disease with a high incidence and mortality rate. The key reason is that the efficacy of the therapeutic drugs is limited, mainly due to insufficient doses of drugs delivered to the lungs. To achieve precise lung cancer diagnosis and treatment, nano‐particles (NPs) pulmonary delivery techniques have attracted much attention and facilitate the exploration of the potential of those in inhalable NPs targeting tumor lesions. Since the therapeutic research focusing on pulmonary delivery NPs has rapidly developed and evolved substantially, this review will mainly discuss the current developments of pulmonary delivery NPs for precision lung cancer diagnosis and therapy. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Respiratory Disease Therapeutic Approaches and Drug Discovery > Emerging Technologies Diagnostic Tools > In Vivo Nanodiagnostics and Imaging
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin, China.
- NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Harbin, China.
ORCID-Profile: Xilin Sun
Förderung
- Heilongjiang Provincial Key Laboratory of Molecular Imaging foundation
- HMU Marshal Initiative Funding
- National Natural Science Foundation of China
- the Natural Science Foundation of Heilongjiang Province
- the Tou-Yan Innovation Team Program of the Heilongjiang Province
Zitieren
APA
A, R., Han, Z., Wang, T., Zhu, M., Zhou, M., & Sun, X. (2024). Pulmonary delivery of nano‐particles for lung cancer diagnosis and therapy: Recent advances and future prospects. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.1933
Vancouver
A R, Han Z, Wang T, Zhu M, Zhou M, Sun X. Pulmonary delivery of nano‐particles for lung cancer diagnosis and therapy: Recent advances and future prospects. WIREs Nanomedicine and Nanobiotechnology. 2024. doi:10.1002/wnan.1933
BibTeX
@article{A2024,
author = {A, Rong and Han, Zhaoguo and Wang, Tianyi and Zhu, Mengyuan and Zhou, Meifang and Sun, Xilin},
title = {Pulmonary delivery of nano‐particles for lung cancer diagnosis and therapy: Recent advances and future prospects},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2024},
doi = {10.1002/wnan.1933}
}
EUVIMED